Tear Science Lipi Flow Thermal Pulsation
Key Features
Built for efficiency
Built with environment in mind
Built for performance
Designed to Improve Gland Function
The TearScience™ LipiFlow™ Thermal Pulsation System consists of a console and a single-use sterile device, known as the Activator, and has a drug-free mechanism of action. Eye care professionals use the TearScience™ LipiFlow™ System to treat MGD patients in-office with confidence and efficiency.
The Science Behind TearScience™ LipiFlow™
Vectored
A vaulted design protects the cornea while multi-point sensors monitor and regulate heat and pressure throughout the treatment. This maximizes results and minimizes discomfort. Along with force equalization, the eye is protected from heat and pressure while a nominal therapeutic temperature of 42.5 degrees Celsius is applied directly to the inner eyelid where the glands are located, while protecting the eyelid or delicate structures of the globe.
Thermal
Proprietary heating technology ensures precise temperature regulation with continuous feedback and consistent heat application to the meibomian glands. The insulated and vaulted design of the Activator protects the cornea from unsafe temperatures
Pulsation
Intelligent pressure feedback loop sends pulsation sequences to expel blockages and stagnant material from the gland. The custom pressure sequence maximizes gland clearing while device design protects the eye from unnecessary intraocular pressure.
Process to Improve Gland Function
The TearScience™ LipiFlow™ System represents more than 14 years of dedicated research and is protected by more than 30 patents. A phased pressure profile with adaptive force equalization and proximal-to-distal peristaltic motion evacuates gland contents as the inner lid is gently heated.
Patient Messaging
Did You Know?
-
In one study, up to 86% of dry eye patients had signs of MGD3
-
Approximately 1 in 5 patients with MGD are asymptomatic4
-
TearScience™ LipiFlow™ has been shown to increase gland secretion threefold, on average, with just one treatment2
-
Safety and long-term effectiveness have been demonstrated in peer-reviewed studies5,6,7
-
TearScience™ LipiFlow™ installations are evenly divided between ophthalmology and optometry clinics
-
TearScience™ LipiFlow™ is available in more than 1500 practice locations in the United States and Canada as of January 2023
There are no reviews yet.